Search

everythinglearnresearchcommunity

for

Search:↓

PCOS skin symptoms need personalized treatment and psychological support to improve quality of life.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

The document concludes that personalized hormonal treatments are important for transgender individuals and more research is needed for non-binary treatments.

A woman's severe male hormone excess was caused by a small, hard-to-find ovarian tumor.

Nanocarriers can improve drug delivery through the skin by overcoming barriers.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

The guidelines help doctors diagnose and treat hormone-related disorders in women.

Medicines that lower androgen levels and hair removal treatments help manage excessive hair and acne in women with PCOS.

Targeting androgen receptors shows promise for treating triple-negative breast cancer, but more research is needed.

Transgender youth have more sleep disorders, but gender-affirming therapy may help reduce them.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

Antiandrogens don't help with COVID-19 and aren't recommended.

Finasteride reduces prostate size and symptoms with few side effects.

Transgender patients in critical care need better-trained medical staff and specific guidelines.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

The ovary mainly causes high testosterone in PCO, while the adrenal gland is the main source in IH.

Leuprolide plus estrogen is more effective than oral contraceptives for reducing hirsutism.

Leuprolide effectively reduces hair growth in hirsute women at higher doses.

Leuprolide may better manage cholesterol and blood pressure in PCOS than spironolactone.

A 7-year-old boy with a brain tumor developed early puberty, which was successfully treated with medication.

An 8-year-old boy's early puberty was caused by a rare hormone-secreting brain tumor, which was successfully treated with surgery.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

Hair loss is a common side effect of hormone treatments for cancer.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Early diagnosis and treatment with Leuprolide are key for children with precocious puberty.

Both finasteride and GnRH agonist treatments reduced hair growth in women with idiopathic hirsutism, but GnRH agonist was more effective.

Letrozole combined with Cabergoline improves ovulation and pregnancy rates in women with PCOS and high prolactin levels compared to Letrozole alone.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.